Ocugen (MEX:OCGN) Cyclically Adjusted FCF per Share: MXN-413.20 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:OCGN Ocugen Inc MEX:OCGN
35 GF Score
Price MXN20.68
GF Value MXN13.07
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Ocugen Cyclically Adjusted FCF per Share?

Ocugen MEX:OCGN 35 Cyclically Adjusted FCF per Share is MXN-413.20 as of Mar. 2026. GuruFocus rates MEX:OCGN with a GF Score™ of 35/100 and a GF Value™ of MXN13.07 (Significantly Overvalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Ocugen's adjusted free cash flow per share for the three months ended in Mar. 2026 was MXN-1.200. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is MXN-413.20 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-08-02), Ocugen's current stock price is MXN20.68. Ocugen's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was MXN-413.20. Ocugen's Cyclically Adjusted Price-to-FCF of today is .


Ocugen  (MEX:OCGN) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Ocugen Cyclically Adjusted FCF per Share Related Terms


Ocugen Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Ocugen's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ocugen Cyclically Adjusted FCF per Share Chart

Ocugen Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -1,020.00 -955.90 -521.15

Ocugen Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -838.31 -749.38 -578.58 -521.15 -413.20

MEX:OCGN vs EVMN, PBYI, LRMR: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Ocugen's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ocugen Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ocugen's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Ocugen's Cyclically Adjusted Price-to-FCF falls into.


MEX:OCGN
35GF Score
Ocugen Inc MEX:OCGN
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ocugen Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Ocugen's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-1.2/330.2130*330.2130
=-1.200

Current CPI (Mar. 2026) = 330.2130.

Ocugen Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -571.122 241.018 -782.481
201609 -475.721 241.428 -650.667
201612 -412.061 241.432 -563.587
201703 -380.811 243.801 -515.784
201706 -276.857 244.955 -373.219
201709 -279.170 246.819 -373.495
201712 -219.128 246.524 -293.517
201803 80.041 249.554 105.911
201806 -274.520 251.989 -359.738
201809 -230.720 252.439 -301.803
201812 -133.134 251.233 -174.987
201903 -122.840 254.202 -159.571
201906 -37.237 256.143 -48.005
201909 10.470 256.759 13.465
201912 -3.134 256.974 -4.027
202003 -2.111 258.115 -2.701
202006 -0.848 257.797 -1.086
202009 -0.417 260.280 -0.529
202012 -0.490 260.474 -0.621
202103 -0.608 264.877 -0.758
202106 -2.246 271.696 -2.730
202109 -0.856 274.310 -1.030
202112 -1.338 278.802 -1.585
202203 -1.480 287.504 -1.700
202206 -1.413 296.311 -1.575
202209 -1.407 296.808 -1.565
202212 -1.677 296.797 -1.866
202303 -1.587 301.836 -1.736
202306 -1.553 305.109 -1.681
202309 -1.159 307.789 -1.243
202312 -0.928 306.746 -0.999
202403 -0.835 312.332 -0.883
202406 -0.742 314.175 -0.780
202409 -0.834 315.301 -0.873
202412 -0.744 315.605 -0.778
202503 -1.357 319.799 -1.401
202506 -0.695 322.561 -0.711
202509 -0.785 324.800 -0.798
202512 -0.806 324.054 -0.821
202603 -1.200 330.213 -1.200

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of MXN-413.20 mean?
Ocugen (MEX:OCGN) has a Cyclically Adjusted FCF per Share of MXN-413.20 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Ocugen and its competitors.
Is Ocugen's Cyclically Adjusted FCF per Share too high?
Ocugen's current Cyclically Adjusted FCF per Share is MXN-413.20. Overall, Ocugen has a GF Score™ of 35/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ocugen's Cyclically Adjusted FCF per Share compare to EVMN and PBYI?
Ocugen's Cyclically Adjusted FCF per Share of MXN-413.20 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Ocugen and its competitors. Ocugen's current Cyclically Adjusted FCF per Share is MXN-413.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ocugen stock overvalued right now?
Based on GuruFocus' analysis, Ocugen (MEX:OCGN) is currently considered Significantly Overvalued. The stock's GF Value™ is MXN13.07, compared to a current price of MXN20.68 — trading 58.2% above its estimated fair value. The current Cyclically Adjusted FCF per Share is MXN-413.20. Ocugen's overall GF Score™ is 35/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Ocugen (MEX:OCGN), the current Cyclically Adjusted FCF per Share is MXN-413.20 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ocugen (MEX:OCGN) Overvalued in 2026?

Based on GuruFocus' analysis, Ocugen stock appears to be overvalued. The current stock price of MXN20.68 is trading 58.2% above its estimated GF Value™ of MXN13.07. GuruFocus considers Ocugen to be Significantly Overvalued.

Key valuation signals for MEX:OCGN:

  • Cyclically Adjusted FCF per Share: MXN-413.20
  • GF Value™: MXN13.07 vs. price of MXN20.68 (58.2% above fair value)
  • GF Score™: 35/100 with 4 warning signs

No single metric tells the full story. See the MEX:OCGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ocugen Business Description

Other Exchanges OCGN:USA2H51:Germany
Address 11 Great Valley Parkway, Malvern, PA, USA, 19355
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
35GF Score

Get the complete analysis for MEX:OCGN

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN20.68
Price
MXN13.07
GF Value